Increased High-Density Lipoprotein Cholesterol Predicts the Pioglitazone-Mediated Reduction of Carotid Intima-Media Thickness Progression in Patients With Type 2 Diabetes Mellitus | Zendy

Michael Davidson | Zendy; Peter Meyer | Zendy; Steven M. Haffner | Zendy; Steven B. Feinstein | Zendy; Ralph B. D’Agostino | Zendy; George T. Kondos | Zendy; Alfonso Pérez | Zendy; Zhen Chen | Zendy; Theodore Mazzone | Zendy

Open Access

Increased High-Density Lipoprotein Cholesterol Predicts the Pioglitazone-Mediated Reduction of Carotid Intima-Media Thickness Progression in Patients With Type 2 Diabetes Mellitus

Author(s) -

Michael Davidson,

Peter Meyer,

Steven M. Haffner,

Steven B. Feinstein,

Ralph B. D’Agostino,

George T. Kondos,

Alfonso Pérez,

Zhen Chen,

Theodore Mazzone

Publication year - 2008

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.107.746610

Subject(s) - pioglitazone , medicine , endocrinology , glimepiride , intima media thickness , triglyceride , cholesterol , diabetes mellitus , apolipoprotein b , high density lipoprotein , insulin resistance , insulin , lipoprotein , body mass index , type 2 diabetes mellitus , type 2 diabetes , cardiology , carotid arteries

Measurement of carotid intima-media thickness (CIMT) has been validated as a measure of atherosclerosis and as a predictor of future cardiovascular events. Compared with glimepiride, pioglitazone has been shown to slow the progression of atherosclerosis measured by CIMT in patients with type 2 diabetes mellitus.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research